Dr. Medha N. Munshi, geriatrician and founder of Joslin's Geriatric Diabetes Program leads research on improving care for ...
In the late 19th century, diabetes was considered a very obscure disease, and there was little in the way of treatment. But, both personal and professional experiences led Elliott P. Joslin, MD to ...
Mary Loeken is an Investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and an Associate Professor in the Department of Medicine at Harvard Medical School. She ...
The Diabetes Remission Outcome Program (DROP) is a 12-week weight management program targeting those who have been diagnosed with diabetes for less than five years, have an A1C less than 8%, and are ...
Gregory Westcott, MD is a staff endocrinologist at Joslin Diabetes Center and Beth Israel Deaconess Medical Center. At Joslin, he treats adult patients with type 1 and 2 diabetes. In addition to ...
Philip M. Silver, OD is a staff optometrist in the Beetham Eye Institute of the Joslin Diabetes Center since 1985. Dr. Silver is Chief of the Vision Rehabilitation Service. He also maintains a contact ...
Matthew Lynes is a Research Associate at Joslin Diabetes Center. He is also an Instructor in Medicine at Harvard Medical School.
Joslin Diabetes Center is part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, and more than ...
We’ve been at the forefront of discovery, and committed to preventing and curing diabetes worldwide. Our Adult Clinic ensures people with diabetes get the most advanced medical care, education and ...
Philanthropy allows the team at Joslin Diabetes Center to provide exceptional care with state-of-the-art equipment. Your gift will support critical research initiatives and allow us to expand ...
Since its founding in 1898, the mission of the Joslin Diabetes Center has been to improve the lives of patients with diabetes through research, clinical care, and education to find new treatments, ...